Literature DB >> 2829182

Carboxyl-terminal mutants of the large tumor antigen of simian virus 40: a role for the early protein late in the lytic cycle.

K Khalili1, J Brady, J M Pipas, S L Spence, M Sadofsky, G Khoury.   

Abstract

Simian virus 40 (SV40) mutants dl1066 and dl1140 contain deletions within the region encoding the carboxyl terminus of the large tumor (T) antigen. Although these mutations have little effect on the efficiency of viral DNA replication, they decrease the yield of infectious virus particles by 3-4 orders of magnitude [Pipas, J. (1985) J. Virol. 54, 569-575]. Here we show that the level of late RNA is lower by a factor of 5-15 in CV-1P monkey cells infected with these mutants compared to cells infected with wild-type SV40. Consistent with this decrease in RNA, synthesis of late viral structural proteins VP1 and VP3 decreases by a factor of 5-15. In contrast, the synthesis of SV40 agnoprotein decreases by a factor greater than 100. Intercistronic complementation of these mutants with pm1493 and dl121, two SV40 mutants that are defective in agnoprotein but encode wild-type T antigen, results in an increased synthesis of agnoprotein in the infected cells. These results suggest that the carboxyl-terminal portion of T antigen participates in the posttranscriptional regulation of agnoprotein.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2829182      PMCID: PMC279546          DOI: 10.1073/pnas.85.2.354

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  22 in total

1.  Splicing of in vitro synthesized messenger RNA precursors in HeLa cell extracts.

Authors:  N Hernandez; W Keller
Journal:  Cell       Date:  1983-11       Impact factor: 41.582

2.  Subcellular localization of the simian virus 40 agnoprotein.

Authors:  S Nomura; G Khoury; G Jay
Journal:  J Virol       Date:  1983-01       Impact factor: 5.103

3.  Attenuation in the control of SV40 gene expression.

Authors:  N Hay; H Skolnik-David; Y Aloni
Journal:  Cell       Date:  1982-05       Impact factor: 41.582

4.  Evidence for simian virus 40 late transcriptional control: mixed infections of wild-type simian virus 40 and a late leader deletion mutant exhibit trans effects on late viral RNA synthesis.

Authors:  J C Alwine
Journal:  J Virol       Date:  1982-06       Impact factor: 5.103

5.  Intracistronic complementation in the simian virus 40 A gene.

Authors:  J Tornow; C N Cole
Journal:  Proc Natl Acad Sci U S A       Date:  1983-10       Impact factor: 11.205

6.  Suppression of a VP1 mutant of simian virus 40 by missense mutations in serine codons of the viral agnogene.

Authors:  R F Margolskee; D Nathans
Journal:  J Virol       Date:  1983-11       Impact factor: 5.103

7.  Posttranscriptional block to synthesis of a human adenovirus capsid protein in abortively infected monkey cells.

Authors:  K P Anderson; D F Klessig
Journal:  J Mol Appl Genet       Date:  1983

8.  Electrophoretic transfer of proteins and nucleic acids from slab gels to diazobenzyloxymethyl cellulose or nitrocellulose sheets.

Authors:  M Bittner; P Kupferer; C F Morris
Journal:  Anal Biochem       Date:  1980-03-01       Impact factor: 3.365

9.  Characterization of a fused protein specified by the adenovirus type 2-simian virus 40 hybrid Ad2+ND1 dp2.

Authors:  G Fey; J B Lewis; T Grodzicker; A Bothwell
Journal:  J Virol       Date:  1979-04       Impact factor: 5.103

10.  Nonviable mutants of simian virus 40 with deletions near the 3' end of gene A define a function for large T antigen required after onset of viral DNA replication.

Authors:  J Tornow; C N Cole
Journal:  J Virol       Date:  1983-09       Impact factor: 5.103

View more
  13 in total

1.  Detection of JC virus DNA sequence and expression of the viral oncoprotein, tumor antigen, in brain of immunocompetent patient with oligoastrocytoma.

Authors:  A Rencic; J Gordon; J Otte; M Curtis; A Kovatich; P Zoltick; K Khalili; D Andrews
Journal:  Proc Natl Acad Sci U S A       Date:  1996-07-09       Impact factor: 11.205

2.  Mapping of helicase and helicase substrate-binding domains on simian virus 40 large T antigen.

Authors:  K Wun-Kim; D T Simmons
Journal:  J Virol       Date:  1990-05       Impact factor: 5.103

3.  Nucleotide sequence of the human polyomavirus AS virus, an antigenic variant of BK virus.

Authors:  J E Tavis; D L Walker; S D Gardner; R J Frisque
Journal:  J Virol       Date:  1989-02       Impact factor: 5.103

4.  Interaction of JC virus agno protein with T antigen modulates transcription and replication of the viral genome in glial cells.

Authors:  M Safak; R Barrucco; A Darbinyan; Y Okada; K Nagashima; K Khalili
Journal:  J Virol       Date:  2001-02       Impact factor: 5.103

5.  Triad of human cellular proteins, IRF2, FAM111A, and RFC3, restrict replication of orthopoxvirus SPI-1 host-range mutants.

Authors:  Debasis Panda; Daniel J Fernandez; Madhu Lal; Eugen Buehler; Bernard Moss
Journal:  Proc Natl Acad Sci U S A       Date:  2017-03-20       Impact factor: 11.205

6.  Infection of CV1 cells expressing the polyoma virus middle T antigen or the SV40 agnogene product with simian virus 40 host-range mutants.

Authors:  S L Spence; L C Tack; J H Wright; S Carswell; J M Pipas
Journal:  In Vitro Cell Dev Biol       Date:  1990-06

7.  Simian virus 40 host range/helper function mutations cause multiple defects in viral late gene expression.

Authors:  T Stacy; M Chamberlain; C N Cole
Journal:  J Virol       Date:  1989-12       Impact factor: 5.103

8.  Simian virus 40 large T antigen host range domain functions in virion assembly.

Authors:  S L Spence; J M Pipas
Journal:  J Virol       Date:  1994-07       Impact factor: 5.103

9.  Genetic analysis of simian virus 40 from brains and kidneys of macaque monkeys.

Authors:  P O Ilyinskii; M D Daniel; C J Horvath; R C Desrosiers
Journal:  J Virol       Date:  1992-11       Impact factor: 5.103

10.  Mapping the transcriptional transactivation function of simian virus 40 large T antigen.

Authors:  J Y Zhu; P W Rice; M Chamberlain; C N Cole
Journal:  J Virol       Date:  1991-06       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.